RBC Capital Reiterates Outperform on Boston Scientific, Maintains $58 Price Target
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Shagun Singh has reiterated an 'Outperform' rating on Boston Scientific (NYSE:BSX) and maintained a $58 price target.
August 28, 2023 | 1:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated an 'Outperform' rating on Boston Scientific and maintained a $58 price target.
The reiteration of an 'Outperform' rating by RBC Capital indicates a positive outlook for Boston Scientific. The maintained price target of $58 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100